![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
PetMed Express Inc | NASDAQ:PETS | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.06 | -1.43% | 4.13 | 4.03 | 4.19 | 4.18 | 4.01 | 4.13 | 460,702 | 21:00:06 |
PetMeds’ management will host the conference call, followed by a question and answer period.
Date: Monday, October 30, 2023Time: 4:30pm Eastern time (1:30pm Pacific time)U.S. dial-in number: 877-407-0791 International number: 201-689-8563Webcast: 2Q Webcast Link
Please call the conference telephone number 5-10 minutes prior to the start time. If you have any difficulty connecting with the conference call, please contact MZ Group at 561-374-0177.
A telephonic replay of the conference call will also be available after 7:30 PM Eastern time on the same day through November 13, 2023.
Toll-free replay number: 844-512-2921International replay number: 412-317-6671 Replay passcode: 13741999
About PetMed Express
Founded in 1996, PetMeds is Your Trusted Pet Health ExpertTM, delivering prescription and non-prescription pet medications and other health products for dogs, cats, and horses at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and through its website at www.petmeds.com.
Forward-Looking StatementsThis press release may contain “forward-looking” statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risks and uncertainties, including the Company’s ability to meet the objectives included in its business plan. Important factors that could cause results to differ materially from those indicated by such “forward-looking” statements are set forth in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the PetMed Express Annual Report on Form 10-K for the year ended March 31, 2023. The Company’s future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company's Form 10-Q and its Annual Report on Form 10-K.
Investor Contact:MZ North AmericaBrian M. Prenoveau, CFAinvestor@petmeds.com(561) 489-5315
1 Year PetMed Express Chart |
1 Month PetMed Express Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions